A single-center, randomized, open-label, two-period, crossover, fasted bioequivalence study: comparing recombinant human follicle-stimulating hormone for injection (JZB30) with Gonal-f® in healthy Chinese female participants

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-11-10
DOI
https://doi.org/10.3389/fphar.2025.1678830
Primary Topic
Ovarian function and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A single-center, randomized, open-label, two-period, crossover, fasted bioequivalence study: comparing recombinant human follicle-stimulating hormone for injection (JZB30) with Gonal-f® in healthy Chinese female participants

Linrui Cai, Qin Zou, Zhuo Chen, Mo Li et al.
Frontiers in Pharmacology
Ovarian function and disorders
article

A single-center, randomized, open-label, two-period, crossover, fasted bioequivalence study: comparing recombinant human follicle-stimulating hormone for injection (JZB30) with Gonal-f® in healthy Chinese female participants

Linrui Cai, Qin Zou, Zhuo Chen, Mo Li, Chunfeng Du, Shiyin Feng, Dan Du, Qin Yu
article en

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
Chengdu Medical College (CN), National Medical Products Administration (CN), Sichuan University (CN), West China Second University Hospital of Sichuan University (CN)
Openalex Percentile: Top 57%
Ovarian function and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.